RT Journal Article
SR Electronic
T1 Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.09.21260257
DO 10.1101/2021.07.09.21260257
A1 Wadim Koslow
A1 Martin J. Kühn
A1 Sebastian Binder
A1 Margrit Klitz
A1 Daniel Abele
A1 Achim Basermann
A1 Michael Meyer-Hermann
YR 2021
UL http://medrxiv.org/content/early/2021/11/29/2021.07.09.21260257.abstract
AB We analyze the relaxation of non-pharmaceutical interventions (NPIs) under an increasing number of vaccinations in Germany. For the spread of SARS-CoV-2 we employ a SIR-type model that accounts for age-dependence and includes realistic contact patterns between age groups. The implementation of NPIs occurs on changed contact patterns, improved isolation, or reduced infectiousness when, e.g., wearing masks. We account for spatial heterogeneity and commuting activities in between regions in Germany, and the testing of commuters is considered as a further NPI. We include the ongoing vaccination process and analyze the effect of the B.1.617.2 (Delta) variant, which is considered to be 40% − 60% more infectious then the currently dominant B.1.1.7 (Alpha) variant. We explore different opening scenarios under the ongoing vaccination process by assuming that local restrictions are either lifted in early July or August with or without continued wearing of masks and testing. Our results indicate that we can counteract the resurgence of SARS-CoV-2 despite the Delta variant with appropriate timing for the relaxation of NPIs. In all cases, however, school children are hit the hardest.Author summary One of the greatest challenges within the Covid-19 pandemic is to identify the timing and amount of non-pharmaceutical interventions (face masks, travel bans, school closures, etc). In the year 2021 more and more people are getting vaccinated. When can we finally lift all restrictions and stop wearing masks? In order to provide more insights to this question, we use a mathematical model which is capable of simulating the effects of non-pharmaceutical interventions in Germany while accounting for age-dependent factors as well as commuting activities between regions. We include the vaccination process and analyze the much more infectious Delta coronavirus variant. We simulate scenarios that consider the timing of the return to pre-pandemic contacts as well as when to suspend wearing masks and testing. Our results show that a later opening by 1 August in combination with masks and testing reduces the chance of a further infection wave considerably. From the retrospective view of the revision, we see that the rise in infections at the end of summer could have been well predicted by our scenarios that considered lifting of NPIs in July as it happened in many places. In all of our scenarios, the infection manifests in the younger age groups.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101003480 and by the Initiative and Networking Fund of the Helmholtz Association. It was supported by German Federal Ministry of Education and Research for the project CoViDec (FKZ: 01KI20102). The funding bodies had no role in the design of the study, collection, analysis, and interpretation of the results, or writing the manuscript. The second author acknowledges the Helmholtz Information & Data Science Academy (HIDA) for providing financial support within the HIDA Trainee Network program enabling a short-term research stay at Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig to analyze data sets that were used as input data for our models.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Does not apply.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe parameters to setup the simulations are provided in the current article and [6]. The simulation output for all different strategies, scenarios and Monte Carlo runs presented here make up multiple GBs cannot be shared easily. Particular results can be shared upon request. The tools to gather and create the corresponding input data as well as the full code is available at: https://github.com/DLR-SC/memilio https://github.com/DLR-SC/memilio